Related Experiment Video
Updated: Aug 10, 2026
08:30
X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
Published on: September 11, 2011
Strategies for Implementing Pediatric Dose Standardization: Considerations From the Vizient University Health System
Christopher T Campbell1, Kristin H Wheatley2, Leanne Svoboda3
1Department of Pharmacy (CTC, CEC, KRN), Augusta University Medical Center, Augusta, GA.
Summary
Implementing pediatric dose standardization can improve medication safety by reducing errors. Successful strategies involve institutional support, customized practices, and leveraging technology to overcome barriers in preparing ready-to-use medications.
Area of Science:
- Pediatric pharmacology
- Medication safety
- Healthcare administration
Background:
- Pediatric patients face higher risks of medication errors due to variability in prescribing and administration.
- Dose rounding and standardization are established methods to mitigate variability and enhance patient safety.
- Current institutional practices show significant variation in dose standardization and ready-to-use (RTU) medication preparation.
Purpose of the Study:
- To outline strategies for implementing pediatric dose standardization.
- To identify barriers and knowledge gaps in preparing and utilizing RTU medications for pediatric populations.
- To provide insights for institutions aiming to enhance RTU medication services.
Main Methods:
- Review of strategies for implementing pediatric dose standardization.
- Analysis of Vizient survey data on dose standardization and RTU practices.
- Discussion of barriers including medication selection, dose calculation, product preparation, and supply chain management.
Main Results:
- Wide variation exists in institutional dose standardization and RTU practices.
- Most institutions attempt to minimize bedside manipulation to reduce medication errors.
- Successful implementations leverage IT systems, multidisciplinary support, and customized operational approaches.
Conclusions:
- Pediatric dose standardization offers a pathway to improved medication safety.
- Overcoming implementation barriers requires strategic planning, technological integration, and stakeholder collaboration.
- Further research is needed to address knowledge gaps in RTU product preparation and use in pediatrics.
More Related Videos
Related Concept Videos
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...